Robert Thomas
Follow
Get notifications in MyBN when activity occurs.
Robert Thomas
Non-Executive Director / Clarity Pharmaceuticals
Robert Thomas has more than 40 years of experience in the securities industry. He is chair of Starpharma Holdings, Aus Bio and Grahger Retail Securities. Mr Thomas is also a director of O’Connell Street Associates, REVA Medical, and Biotron. He was previously a director of Heartware International. Mr Thomas has a Bachelor of Economics from Monash University. He has been a member of the Securities Institute of Australia since 1976 and was appointed as a Fellow to the Institute in 1997. He is a Master Stockbroker and a Fellow of the Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1808th | Biotron | -79% | -22% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Biotron | $1.6m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Clarity Pharmaceuticals | 07 Apr 2022 |
| NEW ROLE: Non-Executive Director, Chair since 2014, Starpharma Holdings | 03 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Biotron | 03 Nov 2020 |
